NYSEAMERICAN:ELMD

Electromed Stock Forecast, Price & News

$10.00
-0.37 (-3.57 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.00
Now: $10.00
$10.46
50-Day Range
$9.48
MA: $9.91
$10.28
52-Week Range
$8.10
Now: $10.00
$19.73
Volume45,689 shs
Average Volume60,455 shs
Market Capitalization$86.35 million
P/E Ratio23.81
Dividend YieldN/A
Beta0.42
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Electromed logo

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:ELMD
Previous SymbolNYSEMKT:ELMD
CUSIPN/A
Phone+1-952-7589299
Employees120
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.47 million
Cash Flow$0.57 per share
Book Value$3.57 per share

Profitability

Net Income$4.16 million

Miscellaneous

Market Cap$86.35 million
Next Earnings Date5/11/2021 (Estimated)
OptionableNot Optionable

Headlines

Electromed, Inc. (ELMD) Q2 Earnings and Revenues Top Estimates
February 11, 2021 |  markets.businessinsider.com
See More Headlines

MarketRank

Overall MarketRank

1.83 out of 5 stars

Medical Sector

130th out of 2,024 stocks

Electromedical Equipment Industry

4th out of 61 stocks

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 2.5 5 -4 -3 -2 -1 -
$10.00
-0.37 (-3.57 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions

Is Electromed a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Electromed stock.
View analyst ratings for Electromed
or view top-rated stocks.

What stocks does MarketBeat like better than Electromed?

Wall Street analysts have given Electromed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Electromed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Electromed's next earnings date?

Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, May 11th 2021.
View our earnings forecast for Electromed
.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) released its earnings results on Monday, February, 8th. The medical equipment provider reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.09. The medical equipment provider earned $9.50 million during the quarter, compared to analysts' expectations of $8.25 million. Electromed had a trailing twelve-month return on equity of 12.39% and a net margin of 11.44%.
View Electromed's earnings history
.

How has Electromed's stock been impacted by Coronavirus?

Electromed's stock was trading at $9.29 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ELMD stock has increased by 7.6% and is now trading at $10.00.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ELMD?

2 brokerages have issued 1 year price targets for Electromed's shares. Their forecasts range from $15.00 to $21.00. On average, they anticipate Electromed's stock price to reach $18.00 in the next year. This suggests a possible upside of 80.0% from the stock's current price.
View analysts' price targets for Electromed
or view top-rated stocks among Wall Street analysts.

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 65, Pay $433.51k)
  • Mr. Michael Joseph MacCourt, CFO, Treasurer & Sec. (Age 43, Pay $266.58k)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George, Sec. (Age 72)
  • Ms. Kathryn Thompson, VP of Reimbursement

Who are some of Electromed's key competitors?

What other stocks do shareholders of Electromed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE).

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Who are Electromed's major shareholders?

Electromed's stock is owned by many different institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.54%) and Morgan Dempsey Capital Management LLC (0.08%).
View institutional ownership trends for Electromed
.

Which major investors are buying Electromed stock?

ELMD stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, and Morgan Dempsey Capital Management LLC.
View insider buying and selling activity for Electromed
or or view top insider-buying stocks.

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $10.00.

How much money does Electromed make?

Electromed has a market capitalization of $86.35 million and generates $32.47 million in revenue each year. The medical equipment provider earns $4.16 million in net income (profit) each year or $0.47 on an earnings per share basis.

How many employees does Electromed have?

Electromed employs 120 workers across the globe.

What is Electromed's official website?

The official website for Electromed is smartvest.com.

Where are Electromed's headquarters?

Electromed is headquartered at 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States.

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299 or via email at [email protected]


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.